Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Goéré D[au]:

Search results

Items: 1 to 50 of 197

1.

Development and internal validation of a diagnostic score for gastric linitis plastica.

Vivier-Chicoteau J, Lambert J, Coriat R, Bonnot PE, Goere D, Roche B, Dior M, Goujon G, Morgant S, Pocard M, Glehen O, Aparicio T, Gornet JM.

Gastric Cancer. 2020 Feb 26. doi: 10.1007/s10120-020-01051-x. [Epub ahead of print]

PMID:
32103376
2.

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.

Boilève A, Maillard A, Wagner M, Dromain C, Laurent C, Bierre ED, Le Sourd S, Audemar F, Ulusakarya A, Guerin-Meyer V, Smisth D, Pezzella V, De Baere T, Goere D, Gelli M, Taieb J, Boige V.

BMC Cancer. 2020 Jan 30;20(1):74. doi: 10.1186/s12885-020-6571-7.

3.

Elective surgery for tumours of the splenic flexure: a French inter-group (AFC, SFCD, FRENCH, GRECCAR) survey.

Manceau G, Benoist S, Panis Y, Rault A, Mathonnet M, Goere D, Tuech JJ, Collet D, Penna C, Karoui M.

Tech Coloproctol. 2020 Feb;24(2):191-198. doi: 10.1007/s10151-019-02143-2. Epub 2020 Jan 14.

PMID:
31939046
4.

ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?

Mariani A, Goere D.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):818. doi: 10.1245/s10434-019-07829-3. Epub 2019 Oct 30. No abstract available.

PMID:
31667730
5.

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases.

Allard MA, Nishioka Y, Beghdadi N, Imai K, Gelli M, Yamashita S, Kitano Y, Kokudo T, Yamashita YI, Sa Cunha A, Vibert E, Elias D, Cherqui D, Goere D, Adam R, Baba H, Hasegawa K.

BJS Open. 2019 May 14;3(5):678-686. doi: 10.1002/bjs5.50174. eCollection 2019 Oct.

6.

Management of colorectal peritoneal metastases: Expert opinion.

Abboud K, André T, Brunel M, Ducreux M, Eveno C, Glehen O, Goéré D, Gornet JM, Lefevre JH, Mariani P, Pinto A, Quenet F, Sgarbura O, Ychou M, Pocard M.

J Visc Surg. 2019 Oct;156(5):377-379. doi: 10.1016/j.jviscsurg.2019.08.002. Epub 2019 Aug 26.

PMID:
31466831
7.

Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.

Garlipp B, Gibbs P, Van Hazel GA, Jeyarajah R, Martin RCG, Bruns CJ, Lang H, Manas DM, Ettorre GM, Pardo F, Donckier V, Benckert C, van Gulik TM, Goéré D, Schoen M, Pratschke J, Bechstein WO, de la Cuesta AM, Adeyemi S, Ricke J, Seidensticker M.

Br J Surg. 2019 Dec;106(13):1837-1846. doi: 10.1002/bjs.11283. Epub 2019 Aug 19.

8.

ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas.

Libanje F, Raingeaud J, Luan R, Thomas Z, Zajac O, Veiga J, Marisa L, Adam J, Boige V, Malka D, Goéré D, Hall A, Soazec JY, Prall F, Gelli M, Dartigues P, Jaulin F.

EMBO J. 2019 Jul 15;38(14):e99299. doi: 10.15252/embj.201899299. Epub 2019 Jun 18.

PMID:
31304629
9.

Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei.

Benhaim L, Faron M, Gelli M, Sourrouille I, Honoré C, Delhorme JB, Elias D, Goere D.

Surg Oncol. 2019 Jun;29:78-83. doi: 10.1016/j.suronc.2019.03.004. Epub 2019 Apr 3.

PMID:
31196498
10.

Multiple colic intussusceptions.

Tzedakis S, Flacs M, Besse B, Goere D.

Clin Case Rep. 2019 May 11;7(6):1265-1266. doi: 10.1002/ccr3.2181. eCollection 2019 Jun.

11.

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, Rat P, Gagnière J, Lefevre JH, Courvoisier T, Kianmanesh R, Vaudoyer D, Rivoire M, Meeus P, Passot G, Glehen O; FREGAT and BIG-RENAPE Networks.

J Clin Oncol. 2019 Aug 10;37(23):2028-2040. doi: 10.1200/JCO.18.01688. Epub 2019 May 14.

PMID:
31084544
12.

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Mercier F, Dagbert F, Pocard M, Goéré D, Quenet F, Wernert R, Dumont F, Brigand C, Passot G, Glehen O; RENAPE Network.

BJS Open. 2018 Sep 27;3(2):195-202. doi: 10.1002/bjs5.97. eCollection 2019 Apr.

13.
14.

Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases.

Mariani A, Gelli M, Sourrouille I, Benhaim L, Faron M, Honoré C, Elias D, Goéré D.

Ann Surg Oncol. 2019 May;26(5):1437-1444. doi: 10.1245/s10434-019-07225-x. Epub 2019 Feb 25.

PMID:
30805806
15.

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry.

Vogin G, Hettal L, Vignaud JM, Dartigues P, Goere D, Ferron G, Heyd B, Bereder JM, Tuech JJ, Glehen O, de Chaisemartin C, Lherm Y, Villeneuve L, Kepenekian V, Marchal F; RENAPE Network.

Ann Surg Oncol. 2019 Mar;26(3):852-860. doi: 10.1245/s10434-018-07153-2. Epub 2019 Jan 11.

PMID:
30635798
16.

Hiatal hernia after oesophagectomy: a large European survey.

Gust L, Nafteux P, Allemann P, Tuech JJ, El Nakadi I, Collet D, Goere D, Fabre JM, Meunier B, Dumont F, Poncet G, Passot G, Carrere N, Mathonnet M, Lebreton G, Theraux J, Marchal F, Barabino G, Thomas PA, Piessen G, D'Journo XB.

Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1104-1112. doi: 10.1093/ejcts/ezy451.

PMID:
30596989
17.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.

Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups.

J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16.

PMID:
30554404
18.

Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry.

Deraco M, Nizri E, Glehen O, Baratti D, Tuech JJ, Bereder JM, Kepenekian V, Kusamura S, Goere D.

Eur J Surg Oncol. 2019 Mar;45(3):371-375. doi: 10.1016/j.ejso.2018.10.065. Epub 2018 Oct 19.

PMID:
30473172
19.

How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort.

Pietrasz D, Turrini O, Vendrely V, Simon JM, Hentic O, Coriat R, Portales F, Le Roy B, Taieb J, Regenet N, Goere D, Artru P, Vaillant JC, Huguet F, Laurent C, Sauvanet A, Delpero JR, Bachet JB, Sa Cunha A.

Ann Surg Oncol. 2019 Jan;26(1):109-117. doi: 10.1245/s10434-018-6931-6. Epub 2018 Oct 25.

PMID:
30362063
20.

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.

BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.

21.

Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?

Gelli M, Huguenin JFL, de Baere T, Benhaim L, Mariani A, Boige V, Malka D, Sourouille I, Ducreux M, Elias D, Goéré D.

Eur J Cancer. 2018 Sep;100:94-103. doi: 10.1016/j.ejca.2018.04.015. Epub 2018 Jul 5.

PMID:
30014885
22.

Postoperative Infectious Complications Impact Long-Term Survival in Patients Who Underwent Hepatectomies for Colorectal Liver Metastases: a Propensity Score Matching Analysis.

Memeo R, de Blasi V, Adam R, Goéré D, Laurent A, de'Angelis N, Piardi T, Lermite E, Herrero A, Navarro F, Sa Cunha A, Pessaux P; French colorectal liver metastases working group - Association Française de Chirurgie (AFC).

J Gastrointest Surg. 2018 Dec;22(12):2045-2054. doi: 10.1007/s11605-018-3854-2. Epub 2018 Jul 10.

PMID:
29992519
23.

Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.

Malgras B, Gayat E, Aoun O, Lo Dico R, Eveno C, Pautrat K, Delhorme JB, Passot G, Marchal F, Sgarbura O, Ferron G, Goéré D, Andre T, Pocard M; RENAPE Network.

Ann Surg Oncol. 2018 Oct;25(11):3271-3279. doi: 10.1245/s10434-018-6631-2. Epub 2018 Jul 5.

PMID:
29978366
24.

Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives.

Goéré D, Sourrouille I, Gelli M, Benhaim L, Faron M, Honoré C.

Surg Oncol Clin N Am. 2018 Jul;27(3):563-583. doi: 10.1016/j.soc.2018.02.011. Review.

PMID:
29935690
25.

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.

Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D, Sugarbaker PH, Baratti D, Quenet F, Bartlett DL, Villeneuve L, Kepenekian V; PSOGI and BIG-RENAPE Working Groups.

Eur J Surg Oncol. 2018 Nov;44(11):1786-1792. doi: 10.1016/j.ejso.2018.05.021. Epub 2018 May 28.

PMID:
29885982
26.

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.

Mahjoubi L, Cecchi F, Massard C, Calabro F, Gazzah A, Bahleda R, Jamme P, Gelli M, Goere D, Lacroix L, Adam J, Heukamp L, Trenta P, Hembrough T, Soria JC, Sternberg C, Ducreux M.

Tumori. 2018 Dec;104(6):NP38-NP41. doi: 10.1177/0300891618763215. Epub 2018 Mar 21.

PMID:
29714649
27.

Major Hepatectomy for Colorectal Liver Metastases in Patients Aged Over 80: A Propensity Score Matching Analysis.

De Blasi V, Memeo R, Adam R, Goéré D, Cherqui D, Regimbeau JM, Rivoire M, Perotto LO, Navarro F, Sa Cunha A, Pessaux P; on behalf of the French Colorectal Liver Metastases Working Group, Association Française de Chirurgie.

Dig Surg. 2018;35(4):333-341. doi: 10.1159/000486522. Epub 2018 Apr 17.

PMID:
29669343
28.

Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer.

Dumont F, Dartigues P, Delga B, Thibaudeau E, Benhaim L, Campion L, Mosnier JF, Raimbourg J, Kerdraon O, Goéré D.

Am J Surg. 2018 Sep;216(3):438-443. doi: 10.1016/j.amjsurg.2018.03.025. Epub 2018 Mar 31.

PMID:
29656991
29.

Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.

Hammoudi N, Eveno C, Lambert J, Maillet M, Glehen O, Goere D, Lourenco N, Allez M, Aparicio T, Pocard M, Gornet JM; BIG-RENAPE working group.

Eur J Surg Oncol. 2018 Jun;44(6):799-804. doi: 10.1016/j.ejso.2018.03.006. Epub 2018 Mar 17.

PMID:
29650418
30.

Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.

Mercier F, Bakrin N, Bartlett DL, Goere D, Quenet F, Dumont F, Heyd B, Abboud K, Marolho C, Villeneuve L, Glehen O; PSOGI Working Group; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Jun;25(6):1668-1675. doi: 10.1245/s10434-018-6464-z. Epub 2018 Apr 10.

PMID:
29637438
31.

Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).

Passot G, Dumont F, Goéré D, Arvieux C, Rousset P, Regimbeau JM, Elias D, Villeneuve L, Glehen O; BIG-RENAPE Surgery Working Group.

Br J Surg. 2018 May;105(6):663-667. doi: 10.1002/bjs.10723. Epub 2018 Mar 26.

PMID:
29579322
32.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.

Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner JM, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S; BIG-RENAPE Group.

Ann Surg Oncol. 2018 May;25(5):1184-1192. doi: 10.1245/s10434-018-6369-x. Epub 2018 Feb 26.

33.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin.

Delhorme JB, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C; French National Network of Peritoneal Surface Malignancies (RENAPE).

Br J Surg. 2018 May;105(6):668-676. doi: 10.1002/bjs.10716. Epub 2018 Feb 7.

PMID:
29412465
34.

Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.

Zajac O, Raingeaud J, Libanje F, Lefebvre C, Sabino D, Martins I, Roy P, Benatar C, Canet-Jourdan C, Azorin P, Polrot M, Gonin P, Benbarche S, Souquere S, Pierron G, Nowak D, Bigot L, Ducreux M, Malka D, Lobry C, Scoazec JY, Eveno C, Pocard M, Perfettini JL, Elias D, Dartigues P, Goéré D, Jaulin F.

Nat Cell Biol. 2018 Mar;20(3):296-306. doi: 10.1038/s41556-017-0027-6. Epub 2018 Feb 5.

PMID:
29403038
35.

Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.

Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Apr;25(4):1094-1100. doi: 10.1245/s10434-017-6299-z. Epub 2017 Dec 13.

PMID:
29238881
36.

Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Jan;25(1):179-187. doi: 10.1245/s10434-017-6141-7. Epub 2017 Oct 25.

PMID:
29071660
37.

Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases: A Propensity Score Matching Analysis.

Memeo R, de Blasi V, Adam R, Goéré D, Piardi T, Lermite E, Turrini O, Navarro F, de'Angelis N, Cunha AS, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC).

World J Surg. 2018 Mar;42(3):892-901. doi: 10.1007/s00268-017-4229-7.

PMID:
28929341
38.

Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.

Le Roy F, Gelli M, Hollebecque A, Honoré C, Boige V, Dartigues P, Benhaim L, Malka D, Ducreux M, Elias D, Goéré D.

Ann Surg Oncol. 2017 Nov;24(12):3640-3646. doi: 10.1245/s10434-017-6033-x. Epub 2017 Aug 28.

PMID:
28849389
39.

Are we reproducible in measurement of NET liver metastasis?

Moalla S, Arfi Rouche J, Foulon S, Caramella C, Ternes N, Planchard D, Goere D, Ducreux M, Scoazec JY, Deschamps F, Dromain C, Baudin E.

Dig Liver Dis. 2017 Oct;49(10):1121-1127. doi: 10.1016/j.dld.2017.05.015. Epub 2017 Jun 28.

PMID:
28844707
40.

Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.

Roy P, Canet-Jourdan C, Annereau M, Zajac O, Gelli M, Broutin S, Mercier L, Paci A, Lemare F, Ducreux M, Elias D, Malka D, Boige V, Goéré D, Jaulin F.

Int J Pharm. 2017 Oct 5;531(1):143-152. doi: 10.1016/j.ijpharm.2017.07.084. Epub 2017 Aug 11.

PMID:
28803938
41.

Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients.

Hadoux J, Terroir M, Leboulleux S, Deschamps F, Al Ghuzlan A, Hescot S, Tselikas L, Borget I, Caramella C, Déandréis D, Goere D, De Baere T, Schlumberger M, Baudin E.

Horm Cancer. 2017 Dec;8(5-6):330-337. doi: 10.1007/s12672-017-0303-8. Epub 2017 Jul 26.

PMID:
28748315
42.

Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes.

Hallet J, Sa Cunha A, Cherqui D, Gayet B, Goéré D, Bachellier P, Laurent A, Fuks D, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie.

World J Surg. 2017 Dec;41(12):3189-3198. doi: 10.1007/s00268-017-4119-z.

PMID:
28717911
43.

Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).

Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, Huguet F, Peiffert D, Siproudhis L, Ducreux M, Bouché O.

Dig Liver Dis. 2017 Aug;49(8):831-840. doi: 10.1016/j.dld.2017.05.011. Epub 2017 May 23. Review.

PMID:
28610905
44.

Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?

Honoré C, Gelli M, Francoual J, Benhaim L, Elias D, Goéré D.

Int J Hyperthermia. 2017 Aug;33(5):505-510. doi: 10.1080/02656736.2017.1306119. Review.

PMID:
28540831
45.

Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI).

Goéré D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH, Glehen O.

Int J Hyperthermia. 2017 Aug;33(5):520-527. doi: 10.1080/02656736.2017.1301576.

PMID:
28540827
46.

The role of image-guided therapy in the management of colorectal cancer metastatic disease.

de Baere T, Tselikas L, Yevich S, Boige V, Deschamps F, Ducreux M, Goere D, Nguyen F, Malka D.

Eur J Cancer. 2017 Apr;75:231-242. doi: 10.1016/j.ejca.2017.01.010. Epub 2017 Feb 24. Review.

PMID:
28237869
47.

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.

Schernberg A, Moureau-Zabotto L, Rivin Del Campo E, Escande A, Ducreux M, Nguyen F, Goere D, Chargari C, Deutsch E.

Oncotarget. 2017 Feb 14;8(7):11579-11588. doi: 10.18632/oncotarget.14584.

48.

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

Gelli M, Huguenin JF, Cerebelli C, Benhaim L, Honoré C, Elias D, Goéré D.

Future Oncol. 2017 Apr;13(10):907-918. doi: 10.2217/fon-2016-0389. Epub 2017 Jan 5. Review.

PMID:
28052691
49.

Leukocytosis and neutrophilia predicts outcome in anal cancer.

Schernberg A, Escande A, Rivin Del Campo E, Ducreux M, Nguyen F, Goere D, Chargari C, Deutsch E.

Radiother Oncol. 2017 Jan;122(1):137-145. doi: 10.1016/j.radonc.2016.12.009. Epub 2016 Dec 24.

PMID:
28024835
50.

Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.

Vychnevskaia K, Dumont F, Agostini J, Julié C, Dartigues P, Lazure T, Boige V, Goéré D, Brouquet A, Penna C, Peschaud F, Benoist S.

Ann Surg Oncol. 2017 May;24(5):1304-1311. doi: 10.1245/s10434-016-5736-8. Epub 2016 Dec 22.

PMID:
28008572

Supplemental Content

Support Center